Daridorexant 50 mg Clinical Trials
4 recruitingDrug
Phase 42Phase 22
Showing 1–4 of 4 trials
Recruiting
Phase 4
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
SleepAlzheimer DiseaseInsomnia Disorder
University Hospital, Montpellier62 enrolled1 locationNCT05924425
Recruiting
Phase 4
Dual Orexin Antagonism and Emotion and Affective Processing Study
Cognitive functioningLearningEmotional Processing
University of Oxford62 enrolled1 locationNCT07267559
Recruiting
Phase 2
Daridorexant to Prevent Post-cardiotomy Delirium
Postoperative DeliriumPostoperative Cognitive Decline
University of Rochester80 enrolled1 locationNCT07217912
Recruiting
Phase 2
Daridorexant for Alzheimer Disease Prevention
Alzheimer Disease (AD)
Douglas Mental Health University Institute240 enrolled1 locationNCT07213349